The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Autologous dendritic cell vaccination (DCVAC/OvCa) added to standard of care therapy in three open-label randomized phase 2 studies in women with advanced stage ovarian cancer (OC).
Lukas Rob
No relevant relationships to disclose
Jirina Bartunkova
Employment or Leadership Position - Sotio
Research Funding - Sotio
David Cibula
Research Funding - Sotio
Pawel Knapp
No relevant relationships to disclose
Zuzana Namestkova
Employment or Leadership Position - Sotio
Radek Spisek
Employment or Leadership Position - Sotio
Jan Waclav
Employment or Leadership Position - Sotio
Peter Mallmann
No relevant relationships to disclose